billion (+28% YoY), driven by volume growth from newly acquired assets and improved margin in Integrated PET (Western market contracts) Core EBITDA margin was 12% (-1% YoY),wherein improvements in Core
13% to 13% and 20% yoy. It was driven by the outstanding profit for the Company and its subsidiary. In addition, the significant improvement of return on equity was from the decrease of shareholders
million in quarter 2 /2018 escalating from THB 1.54 million of the same period last year. Such growth was driven mainly from marketing activities rendered to a corporate customer. Jan – Jun. 2018 Business
September 30, 2018 Return on Assets and Return on Equity in 9 months 2018 improved from 12.9% and 14.6% to 13.5% and 19.9% yoy. It was driven by the outstanding profit for the Company and its subsidiary. In
factors and business models. The overall economic growth in 2018 is expected to be 4.5 percent, driven by both domestic and external demand. Nevertheless, the Thai economy continues to face downside risks
12.20 14.36% The increase in revenue came from sales increment in Wellness & Anti-Aging products by the amount of 47.77 million baht which grew by 15.90 million baht or 49.90%. The increment mainly driven
million, in line with increase in total assets. Total shareholders’ equity increased by Baht 479.75 million driven by increase of profit during the period. 3) Key Financial Performance Q1 2020 Q2 2020 Q3
. Dr.Praphakorn Smiti Independent Director and Member of the Audit Committee 9. Colonel Phanthip Katipagdeetham Independent Director and Member of the Audit Committee 6. Approved of the change of the authorized
the ordinary shares in excess of their rights at the same offering price, whereby the Board of Directors or Executive Committee or Chief of Executive Committee or Managing Director shall be authorized